Yahoo Web Search

  1. TEVA's full-year Zacks Consensus Estimates are calling for earnings of $2.39 per share and revenue of $17.28 billion. As such, positive estimate revisions reflect analyst optimism about ...

  2. Scpharmaceuticals Inc (NASDAQ: SCPH) Vaxart Inc (NASDAQ: VXRT) Viveve Medical Inc (NASDAQ: VIVE) Teva Pharmaceutical Industries Ltd (NYSE: TEVA) Intercept ...

  3. NYSE: MRK) announced FDA approval for its Keytruda as a monotherapy for first-line treatment of patients with stage 3 non-small...

  4. Stocks recently featured in the blog include: Pfizer PFE, Teva TEVA, Novartis NVS, Merck MRK and AstraZeneca AZN. This week Pfizer and Teva gained marketing approval from ...

  5. ...: NOVN) Nuvectra Corp (NASDAQ: NVTR) Revance Therapeutics Inc (NASDAQ: RVN) Sensus Healthcare Inc (NASDAQ: SRTS) SI-Bone Inc (NASDAQ: SIBN) Unum Therapeutics Inc (NASDAQ: UMRX) Verastem Inc (NASDAQ: VSTM) Teva Pharmaceutical Industr...

  6. Supreme Court on Monday cast aside pharmaceutical company Allergan Plc's unorthodox bid to shield patents from a federal administrative court's review by transferring them to a Native ...

  7. Allergan plc’s AGN shares declined almost 1% presumably due to the U.S. Supreme Court’s unfavorable ruling in a litigation related to patents covering its blockbuster eye drug, Restasis per ...

  8. BioDelivery (BDSI) Buys US Rights to Pain Drug for $30M

    Zacks via Yahoo FinanceApr 11 13:34 PM

    BioDelivery Sciences International, Inc. BDSI announced that it has inked an exclusive licensing agreement with Japanese pharma company, Shionogi, acquiring U.S. commercial rights to the latter's ...

  9. The results were presented at the 2019 American Association of Clinical Endocrinologists Annual Scientific and Clinical Congress, held April 24 – 28, in Los Angeles, California The stock climbed ...

  10. Teva Pharmaceutical Industries Ltd said on Tuesday it would stop developing its migraine drug, Ajovy, for treating cluster headaches after the company found the treatment ...

  1. Ad
    related to TEVA PHARMACEUTICAL INDUSTRIES LTD